Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress

Balkan, J.; Doğru-Abbasoğlu, S.; Kanbāgli Ö.; Çevikbaş, U.; Aykaç-Toker, G.; Uysal, M.
May 2001
Human & Experimental Toxicology;May2001, Vol. 20 Issue 5, p251
Academic Journal
Thioacetamide (TAA) administration (0.3 g/l of tap water for a period of 3 months) to rats resulted in hepatic cirrhosis as assessed by biochemical and histopathological findings. This treatment caused an increase in the levels of malondialdehyde (MDA) and diene conjugates (DCs) and a decrease in the levels of glutathione (GSH), vitamin E, vitamin C and the activities of glutathione peroxidase (GSH-Px) in the liver of rats. Superoxide dismutase (SOD) activities were unchanged. Taurine (2% w/w, added to the chow diet) was administered together with TAA (0.3 g/l of drinking water) for 3 months. Taurine was found to decrease TAA-induced hepatic lipid peroxidation and to increase TAA-depleted vitamin E levels and GSH-Px activities. Histopathological findings also suggested that taurine has an inhibitive effect on TAA-induced hepatic cirrhosis. These results indicate that taurine treatment has a protective effect against TAA-induced liver cirrhosis by decreasing oxidative stress. Human & Experimental Toxicology (2001) 20, 251–254.


Related Articles

  • Effect of Antioxidant Treatment on Fibrogenesis in Rats with Carbon Tetrachloride-Induced Cirrhosis. Bona, Silvia; Filippin, Lidiane Isabel; Di Naso, FábioCangeri; de David, Cintia; Valiatti, Bruna; Schaun, Maximiliano Isoppo; Xavier, Ricardo Machado; Marroni, Norma Possa // ISRN Gastroenterology;2012, p1 

    Aim. This study aimed to assess the antioxidant activity of quercetin (Q) in an experimental model of cirrhosis induced by CCl4 inhalation. Materials and Methods. We used 25 male Wistar rats (250 g) that were divided into 3 groups: control (CO), CCl4, and CCl4 + Q. The rats were subjected to...

  • Protective effect of aqueous extract of Leonotis nepaetifolia (L.)R.Br.on CCL4 induced hepatic damage. Radhika, J.; Pradeep, V.; Brindha, P. // Journal of Pharmacy Research;Mar2011, Vol. 4 Issue 3, p630 

    Liver is one of the most important organs in the biotransformation of food, drugs, and endogenous and exogenous substances. Herbal plants have been recently popularized in modern medicine, since many therapeutically important compounds are derived from them. From the literature review it is...

  • Prescribing Medications in Patients with Decompensated Liver Cirrhosis. Amarapurkar, Deepak N. // International Journal of Hepatology;2011, p1 

    Patients with decompensated liver cirrhosis have various serious complications which require multiple drugs for therapeutic or prophylactic use. Majority of the drugs are primarily metabolized and excreted by hepatobiliary system; hence, liver cell necrosis contributes to impaired drug handling...

  • Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver. Iguchi, Hiroyoshi; Oda, Masaya; Yamazaki, Hitoshi; Yokomori, Hiroaki // Medical Molecular Morphology;Sep2013, Vol. 46 Issue 3, p123 

    The pathophysiology of arterial capillary proliferation accompanying fibrosis in human cirrhosis remains unclear. However, evidence regarding the molecules participating in the pathophysiological process has been accumulating. Water channel proteins known as aquaporins (AQP)s, notably AQP-1,...

  • Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. Franca, Alex Vianey Callado; Giordano, Helena maria; Sev á-Pereira, Tiago; Soares, Elza Cotrim // Journal of Gastroenterology;2002, Vol. 37 Issue 2, p119 

    Background. The aim of this study was to determine whether a short course of ceftriaxone was sufficient to cure spontaneous bacterial peritonitis (SBP) in cirrhotic patients. Methods. We studied 33 cirrhotic patients with SBP. All of them were treated with ceftriaxone, 1.0 g IV, every 12 h...

  • Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Román, Eva; Torrades, Mª; Nadal, Mª; Cárdenas, Guillem; Nieto, Juan; Vidal, Sílvia; Bascuñana, Helena; Juárez, Cándido; Guarner, Carlos; Córdoba, Juan; Soriano, Germán // Digestive Diseases & Sciences;Aug2014, Vol. 59 Issue 8, p1966 

    Background: Physical exercise could improve functional limitations, muscle mass, and health-related quality of life (HRQoL) in patients with cirrhosis. Aim: The purpose of this study was to evaluate the efficacy and safety of an exercise programme and leucine supplementation to increase exercise...

  • The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care. Figueiredo, Antonio; Romero-Bermejo, Francisco; Perdigoto, Rui; Marcelino, Paulo // Critical Care Research & Practice;2012, p1 

    Liver cirrhosis (LC) can lead to a clinical state of liver failure, which can exacerbate through the course of the disease. New therapies aimed to control the diverse etiologies are now more effective, although the disease may result in advanced stages of liver failure, where liver...

  • Perioperative Anaesthetic Management of Caesarean Delivery in a Parturient with Portal Gastropathy. Ramaswamy, Ashwini H.; Shaikh, Safiya I.; Kaur, Jasvinder // Indian Anaesthetists' Forum;Dec2014, Vol. 15 Issue 13, p1 

    Portal hypertensive gastropathy occurs both in cirrhotic and non-cirrhotic patients leading to hematemesis secondary to oesophageal varices. The hyper dynamic circulatory state of pregnancy in these patients poses special problems necessitating specialised care preferably in a tertiary care...

  • Treatment of Hyponatremia in Cirrhosis. Gorospe, Emmanuel C. // Internet Journal of Gastroenterology;2008, Vol. 7 Issue 2, p14 

    A letter to the editor is presented in response to the article about pathophysiology and management of hyponatremia in patients with cirrhosis and ascites.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics